|Bid||22.74 x 1000|
|Ask||0.00 x 800|
|Day's range||56.21 - 59.40|
|52-week range||46.93 - 93.80|
|Beta (5Y monthly)||1.19|
|PE ratio (TTM)||N/A|
|Earnings date||08 Mar 2022 - 14 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||93.20|
Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) is possibly approaching a major achievement in its business, so we...
SANTA BARBARA, Calif., June 06, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 10:30 am Eastern Time.
Insiders who bought US$4.5m worth of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) stock in the last year have seen...